Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | EDTXF |
---|---|---|
09:32 ET | 25000 | 0.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Spectral Medical Inc | 90.5M | -7.6x | --- |
Odonate Therapeutics Inc | 52.7M | -0.7x | --- |
PharmaCyte Biotech Inc | 55.6M | -11.0x | --- |
Global Pharmatech Inc | 55.3M | -2.1x | --- |
Equillium Inc | 39.8M | -0.5x | --- |
ASP Isotopes Inc | 62.5M | 0.0x | --- |
Spectral Medical Inc. is a Canada-based company that develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's EAA. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development as well as in products manufactured by other diagnostic companies. The Company through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. Its dialysis machine, SAMI is targeting the acute RRT market, while its home hemodialysis machine, DIMI is targeting the chronic RRT market.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $68.0M |
---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 278.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-0.03 |
Book Value | $0.01 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 54.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -682.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.